4 insiders bought €3.4M of shares over the last 90 days, the latest by 유영일, filed 21 Sept 2026.
Who traded when
BuySaleSince the insiders bought
- +31.4%Entry ₩5,872 · Close at T+365 ₩7,716
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 22,998 sharesShareKRXDART:20260921000066Canonical exit: 20 Dec 2026 (T+90)
- 280,003 sharesShareKRXDART:20260921000063Canonical exit: 20 Dec 2026 (T+90)
- 281,570 sharesShareKRXDART:20260921000062Canonical exit: 20 Dec 2026 (T+90)
- 12,862 sharesShareKRXDART:20260921000069Canonical exit: 20 Dec 2026 (T+90)
- Other0DART
- 646 sharesShareKRXDART:20260916000046Canonical exit: 15 Dec 2026 (T+90)
- 16,806 sharesShareKRXDART:20260916000040Canonical exit: 15 Dec 2026 (T+90)
- Other0DART
- Other0DART
- 987 sharesShareKRXDART:20260916000049Canonical exit: 15 Dec 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 16,427 sharesShareKRXDART:20260814001678Canonical exit: 12 Nov 2026 (T+90)
- 8,644 sharesShareKRXDART:20260814001548Canonical exit: 12 Nov 2026 (T+90)
- 108,788 sharesShareKRXDART:20260814001527Canonical exit: 12 Nov 2026 (T+90)
- 109,399 sharesShareKRXDART:20260814001498Canonical exit: 12 Nov 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 63 declarations
About FutureChem Co.,Ltd
At 퓨쳐켐 (FutureChem Co.,Ltd), one filer explains most of the sales: 길희섭 (상무이사) files 29 of the 55 filings, with 3 purchases and 26 sales, including the record's only sale with an amount, EUR 295,728 on April 4, 2022. By contrast, purchases come from executives: 지대윤 (대표이사) signs 6, including the only purchase with an amount, EUR 43,339 on February 28, 2023, 박영자 (전무이사) 4 and 유영일 (상무이사) 3. The company has 11 filings with no trade.
In all, 26 sales against 16 purchases: 38% purchases among open-market trades. On the calendar, 18 filings were published in 2026, against 31 in 2022, 3 in 2023 and one a year in 2021, 2024 and 2025. From September 16 to September 21, 2026, 4 distinct filers bought.
Read moreShow less
South Korean health care capitalised at KRW 199.2 billion, 11.6% of the capital with insiders, 5 filers. The 18 filings of the latest year include 11 purchases and no sale.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
